Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatment.
Panjasawatwong N, Avihingsanon A, Menétrey C, Ribeiro I, Salvadori N, Swanson A, Gillon J-Y, Tan S-S, Thanprasertsuk S, Thongsawat S, Cressey TR; STORM-C-1 study team. Panjasawatwong N, et al. Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0000824. doi: 10.1128/aac.00008-24. Epub 2024 May 20. Antimicrob Agents Chemother. 2024. PMID: 38767383
Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis.
Ibnou Zekri Lassout N, Goyal V, Krantz E, Simon F, Neven A, Eriksson J, Saayman A, Satam V, Ruffell C, Victor S, Chenel M, Celebic A, Caplain H, Gillon JY, Deshmukh A, Antarkar A, Sjögren E, Ribeiro I. Ibnou Zekri Lassout N, et al. Among authors: gillon jy. Clin Transl Sci. 2024 Sep;17(9):e13908. doi: 10.1111/cts.13908. Clin Transl Sci. 2024. PMID: 39291723 Free PMC article. Clinical Trial.
Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers.
Goyal V, Krantz E, Simon F, Neven A, Eriksson J, Saayman A, Ibnou Zekri Lassout N, Louis M, Robinson S, Deshmukh A, Antarkar A, Ruffell C, Victor S, Chenel M, Celebic A, Caplain H, Gillon JY, Ribeiro I. Goyal V, et al. Among authors: gillon jy. Clin Transl Sci. 2024 Mar;17(3):e13756. doi: 10.1111/cts.13756. Clin Transl Sci. 2024. PMID: 38488418 Free PMC article. Clinical Trial.
Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects.
Gillon JY, Dennison J, van den Berg F, Delhomme S, Dequatre Cheeseman K, Peña Rossi C, Strub Wourgaft N, Specht S, Pedrique B, Monnot F, Skrabs S, Rodriguez ML, Stass H. Gillon JY, et al. Br J Clin Pharmacol. 2021 Oct;87(10):3949-3960. doi: 10.1111/bcp.14816. Epub 2021 Mar 31. Br J Clin Pharmacol. 2021. PMID: 33759250 Free PMC article. Clinical Trial.
19 results